AAAAAA
Results:
1-18
|
Results: 18
Authors:
MALCOLM GP
JODRELL DI
MACLELLAN A
SWAROOP GR
KELLY PAT
WHITTLE IR
Citation: Gp. Malcolm et al., EFFECTS OF NITRIC-OXIDE MANIPULATION ON THE DISPOSITION OF PLATINUM IN AN EXPERIMENTAL GLIOMA MODEL, NeuroReport, 9(2), 1998, pp. 181-185
Authors:
CUMMINGS J
MACPHERSON JS
SMYTH JF
JODRELL DI
Citation: J. Cummings et al., NOVEL MECHANISM OF DRUG-RESISTANCE TO TOPOISOMERASE-I (TOPO-I) INHIBITORS, Annals of oncology, 9, 1998, pp. 234-234
Authors:
JODRELL DI
BOWMAN A
RYE R
DAWSON L
BYRNE B
GAMBA E
SMYTH JF
Citation: Di. Jodrell et al., A CLINICAL-PHASE-I STUDY OF THE NOVEL ANTHRACENEDIONE ANALOG, BBR-2778, ADMINISTERED INTRAVENOUSLY, 3 WEEKLY, Annals of oncology, 9, 1998, pp. 451-451
Authors:
ROSARIO MC
THOMSON AH
JODRELL DI
SHARP CA
ELLIOTT HL
Citation: Mc. Rosario et al., POPULATION PHARMACOKINETICS OF GENTAMICIN IN PATIENTS WITH CANCER, British journal of clinical pharmacology, 46(3), 1998, pp. 229-236
Authors:
MACPHERSON JS
CUMMINGS J
SMYTH JF
JODRELL DI
Citation: Js. Macpherson et al., INVOLVEMENT OF BCL-2 FAMILY MEMBERS IN DRUG-RESISTANCE TO TOPOISOMERASE-I (TOPO-I) INHIBITORS, British Journal of Cancer, 78, 1998, pp. 21-21
Authors:
MACKEAN MJ
CASSIDY J
JODRELL DI
PAUL J
REED NS
CANNEY PA
YOSEF H
HABESHAW T
ROBERTSON AG
MCINNES A
TWELVES CJ
Citation: Mj. Mackean et al., BOLUS INFUSIONAL 5-FLUOROURACIL AND FOLINIC ACID - A REPORT ON 2 PROSPECTIVE, CONSECUTIVE PHASE-II STUDIES WITH 5-FLUOROURACIL DOSE-ESCALATION/, British Journal of Cancer, 77(9), 1998, pp. 1480-1486
Authors:
JODRELL DI
BOWMAN A
STEWART M
DUNLOP N
FRENCH R
MACLELLAN A
CUMMINGS J
SMYTH JF
Citation: Di. Jodrell et al., DOSE LIMITING NEUROTOXICITY IN A PHASE-I STUDY OF PENCLOMEDINE (NSC-388720, CRC-88-04), A SYNTHETIC ALPHA-PICOLINE DERIVATIVE, ADMINISTEREDINTRAVENOUSLY, British Journal of Cancer, 77(5), 1998, pp. 808-811
Authors:
JODRELL DI
MURRAY LS
HAWTOF J
GRAHAM MA
EGORIN MJ
Citation: Di. Jodrell et al., A COMPARISON OF METHODS FOR LIMITED-SAMPLING STRATEGY DESIGN USING DATA FROM A PHASE-I TRIAL OF THE ANTHRAPYRAZOLE DUP-941, Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 356-362
Authors:
EISENBERGER MA
SINIBALDI VJ
REYNO LM
SRIDHARA R
JODRELL DI
ZUHOWSKI EG
TKACZUK KH
LOWITT MH
HEMADY RK
JACOBS SC
VANECHO D
EGORIN MJ
Citation: Ma. Eisenberger et al., PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMENOF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2174-2186
Authors:
EISENBERGER MA
REYNO LM
JODRELL DI
Citation: Ma. Eisenberger et al., SURAMIN, AN ACTIVE-DRUG FOR PROSTATE-CANCER - INTERIM OBSERVATIONS INA PHASE-I TRIAL (VOL 85, PG 611, 1993), Journal of the National Cancer Institute, 86(8), 1994, pp. 639-640
Authors:
JODRELL DI
OSTER W
KERR DJ
CANNEY PA
YOSEF H
STEWARD WP
KAYE SB
CASSIDY J
Citation: Di. Jodrell et al., A PHASE I-II STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ADDEDTO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLORECTAL-CANCER, European journal of cancer, 30A(7), 1994, pp. 950-954
Authors:
JODRELL DI
REYNO LM
SRIDHARA R
EISENBERGER MA
TKACZUK KH
ZUHOWSKI EG
SINIBALDI VJ
NOVAK MJ
EGORIN MJ
Citation: Di. Jodrell et al., SURAMIN - DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND ITS USE WITH INTERMITTENT SHORT INFUSIONS TO CONTROL PLASMA DRUG CONCENTRATION IN PATIENTS WITH PROSTATE-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 166-175
Authors:
EGORIN MJ
REYNO LM
CANETTA RM
JODRELL DI
SWENERTON KD
PATER JL
BURROUGHS JN
NOVAK MJ
SRIDHARA R
Citation: Mj. Egorin et al., MODELING TOXICITY AND RESPONSE IN CARBOPLATIN-BASED COMBINATION CHEMOTHERAPY, Seminars in oncology, 21(5), 1994, pp. 7-19
Authors:
JODRELL DI
MURRAY LS
REED NS
CANNEY PA
KAYE SB
CASSIDY J
Citation: Di. Jodrell et al., BOLUS INFUSIONAL 5-FLUOROURACIL AND FOLINIC ACID FOR METASTATIC COLORECTAL-CARCINOMA - ARE SUBOPTIMAL DOSAGES BEING USED IN THE UK/, British Journal of Cancer, 70(4), 1994, pp. 749-752
Authors:
REYNO LM
EGORIN MJ
CANETTA RM
JODRELL DI
SWENERTON KD
PATER JL
BURROUGHS JN
NOVAK MJ
SRIDHARA R
Citation: Lm. Reyno et al., IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1156-1164
Authors:
KOBAYASHI K
JODRELL DI
RATAIN MJ
Citation: K. Kobayashi et al., PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS AND THERAPEUTIC DRUG-MONITORING, Cancer surveys, 17, 1993, pp. 51-78
Authors:
JODRELL DI
GIBSON W
BISSET GMF
BOYLE FT
JUDSON IR
JACKMAN AL
Citation: Di. Jodrell et al., THE IN-VIVO METABOLIC STABILITY OF DIPEPTIDE ANALOGS OF THE QUINAZOLINE ANTIFOLATE, ICI-198583, IN MICE, Biochemical pharmacology, 46(12), 1993, pp. 2229-2234
Authors:
JODRELL DI
EGORIN MJ
CANETTA RM
LANGENBERG P
GOLDBLOOM EP
BURROUGHS JN
GOODLOW JL
TAN S
WILTSHAW E
Citation: Di. Jodrell et al., RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND TUMOR RESPONSE AND TOXICITY IN PATIENTS WITH OVARIAN-CANCER, Journal of clinical oncology, 10(4), 1992, pp. 520-528
Risultati:
1-18
|